Abstract - Journal of Clinical and Experimental Toxicology (2020) Volume 4, Issue 4
Development and Characterization of pH sensitive liposomes for macrophage targeting using prime-boost vaccination strategy for Pulmonary Tuberculosis
Tuberculosis (TB) caused by the bacterium Mycobacterium tuberculosis remains a major health problem worldwide. Although BCG seems to provide protection against miliary tuberculosis, its effect on pulmonary TB in adults is poor, and needs a better vaccine regimen to combat the disease. Various strategies have been postulated for the development of the tuberculosis vaccine viz. improving the current BCG vaccine, over expression of the immunodominant antigens, endosomal escape, recombinant fusion proteins and a hybrid approach which is a multiphase vaccine that can be administered regardless of the infection status of the individual and with activity both in naïve and already infected individuals. The present investigation was aimed to develop liposome based DNA prime-protein boost vaccine regimen against pulmonary tuberculosis. The rationale behind the use of liposomes as delivery systems in intracellular infections such as mycobacteria is selective uptake by the macrophages, following systemic administration and versatility to engineer to target the specific site in the body via binding to specific receptors.
Two types of multilamellar liposomes (MLVs) were prepared, one ligand directed while the other pH sensitive cationic. Liposomes were developed using DRV (dehydration-rehydration vesicles) and film hydration technique using trehalose dibehenate (TDB) as a protein stabilizer. O-palmitoyl mannan (OPM) was used to coat the ligand directed liposomes to impart them the desired targetability for the alveolar macrophages. Plasmid DNA encoding genes for Ag85A were adsorbed on the preformed pH sensitive cationic liposomes whereas rAg85A was entrapped in the ligand directed (OPM coated) liposomes.